AcouSort
10.5
SEK
-0.47 %
ACOU
First North Stockholm
Medical Equipment & Services
Health Care
Be the first to follow this company
-0.47%
-31.82%
-28.57%
-24.46%
-32.48%
-32.04%
-58.48%
+10.07%
+33.06%
acousort.com/investor
AcouSort is active within medical technology. The company conducts research and development in a proprietary platform technology that utilises ultrasound to separate and analyse composition of biological cells. The technology is mainly used in the analysis of various cases of cancer as well as sepsis. Part of the research is done together with other stakeholders within field. The company was founded in 2010 and is based in Lund.
Revenue
5.53M
EBIT %
-316.27 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
ACOU
Daily low / high price
10.4 / 11.2
SEK
Market cap
156.81M SEK
Turnover
116.13K SEK
Volume
11K
Financial calendar
Annual report
26.02.2025
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Avanza Pension | 10.2 % | 10.2 % |
| Thomas Laurell | 7.4 % | 7.4 % |
| Stefan Scheding | 6.1 % | 6.1 % |
| Freltec ApS | 5.9 % | 5.9 % |
| Lars Svensson | 3.5 % | 3.5 % |
| Nordnet Pensionsförsäkring | 3.1 % | 3.1 % |
| SHB Luxembourg CL ACCT Sweden | 3.0 % | 3.0 % |
| Johan Nilsson | 2.1 % | 2.1 % |
| Lundin, Per | 1.5 % | 1.5 % |
ShowingAll content types
AcouSort AB - Interim Report for the period July - September 2024
AcouSort secures working capital through H1, 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools